Submitted by Anonymous (not verified) on 4 July 2024 - 14:07
Human medicines European public assessment report (EPAR): Grasustek, pegfilgrastim, Date of authorisation: 20/06/2019, Revision: 5, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Grasustek, pegfilgrastim, Date of authorisation: 20/06/2019, Revision: 5, Status: Authorised